{"changes":[],"country":"FR","description":"ReST Therapeutics develops FENM, a small molecule that modulates NMDA-receptor activity to treat central nervous system disorders such as PTSD and Alzheimer's. It targets patients with neurodegenerative and stress-related conditions. Its NMDA-subtype modulation aims to halt disease progression, not just relieve symptoms.","domain":"rest-therapeutics.com","employees":null,"founded":2020,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"biotech","investors":[],"lat":43.6108,"lng":3.8767,"location":"Montpellier, France","name":"Rest Therapeutics","rounds":[{"amountQuarantined":false,"amountUsd":2700000,"currency":"EUR","date":"2023-07-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-08","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"rest-therapeutics-com","sources":[{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-08","status":"attributed","url":null},{"fact":"existence","publisher":"rest-therapeutics.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://rest-therapeutics.com"},{"fact":"description","publisher":"rest-therapeutics.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://rest-therapeutics.com"}],"stage":null,"techStack":[],"totalRaisedUsd":5000000,"updatedAt":"2026-05-08"}